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Thrombospondin-1 (TSP-1) is an endogenous activator of
transforming growth factor-b (TGF-b), and an anti-angiogenic
factor, which may prevent kidney repair. Here we
investigated whether TSP-1 is involved in the development of
chronic kidney disease using rats with unilateral ureteral
obstruction, a well-known model to study renal fibrosis.
Obstruction of 10 days duration induced inflammation,
tubular cell atrophy, dilation, apoptosis, and proliferation,
leading to interstitial fibrosis. TSP-1 expression was increased
in parallel to that of collagen III and TGF-b. Relief of the
obstruction at day 10 produced a gradual improvement in
renal structure and function, the reappearance of peritubular
capillaries, and restoration of renal VEGF content over a 7- to
15-day post-relief period. TSP-1 expression decreased in
parallel with that of TGF-b1 and collagen III. Mice in which the
TSP-1 gene was knocked out displayed less inflammation and
had better preservation of renal tissue and the peritubular
capillary network compared to wild-type mice. Additional
studies showed that the inflammatory effect of TSP-1 was
mediated, at least in part, by monocyte chemoattractant
protein-1 and activation of the Th17 pathway. Thus, TSP-1 is
an important profibrotic and inflammatory mediator of renal
disease. Blockade of its action may be a treatment against the
development of chronic kidney disease.
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Chronic kidney diseases (CKDs) are a growing health
problem. Renal fibrosis, especially interstitial fibrosis, is a
final common pathway that leads to progressive loss of renal
function in various CKDs. Our group and other investigators
as well have investigated over the past years the mechanisms
involved in the development of renal fibrosis in order to
identify targets for therapy.1–5 We were among the first few
groups to report that regression of renal fibrosis was achieved
following angiotensin II receptor antagonist at least in
experimental models of hypertensive nephropathies.6–8 These
results were independently confirmed and extended to
additional experimental models of nephropathies by other
investigators.9–11 As angiotensin II blockade is currently used
and renal function still declines in most CKD patients, we
believe that additional therapeutic approaches are required to
improve renal function in CKD patients.
In addition to etiologic and nephroprotective treatments,
facilitating renal repair represents a promising approach. Stem
cell therapy has raised important hope to replace damaged
tissues and promote renal repair.12 Despite a better char-
acterization of stem cells, their use remains too early for
clinical application. On the other hand, the kidney possesses a
remarkable capacity to regenerate. Most of the time, following
acute kidney injury, the kidney heals. The model of ischemia/
reperfusion has been used to identify molecular mechanisms
central to repair.13 Unilateral ureteral obstruction (UUO)
generates progressive renal fibrosis.14 It is considered as a
model of renal interstitial fibrosis, although reversal of the
obstruction permits the study of recovery. To date, most
studies have investigated renal recovery after a few days of
obstruction-generating tubular injury and dysfunction.15,16
Renal repair after a longer time of UUO has been successfully
demonstrated, but cellular and molecular mechanisms of
renal repair after UUO release are largely unknown.17,18
Our goals were to show the endogenous capacity of the
kidney to regenerate after severe injury induced by 10 days of
UUO, and to investigate cellular and molecular mechanisms
involved during the phase of repair. We focused our study on
thrombospondin-1 (TSP-1), because it is an endogenous
activator of transforming growth factor-b (TGF-b1), and an
anti-angiogenic factor, which may prevent kidney repair.19,20
TSP-1 is a 450-kDa homotrimeric extracellular matrix protein
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with multiple domains that interact with different receptors,
proteins, and proteoglycans.21 Three regions of TSP-1 have
been implicated in its anti-angiogenic property: the procolla-
gen domain, the three type 1 repeats (TSRs), and the C-
terminal domain. We used TSP-1 knockout mice (TSP-1 KO)
to emphasize its major role in fibrosis development and repair.
Our findings show that renal repair involved an early
decrease in TSP-1 and TGF-b1 expression followed by
reappearance of peritubular capillaries, and regeneration of
the proximal tubule. As TSP-1 inhibition reduced TGF-b
renal content, prevented peritubular capillary rarefaction, and
attenuated inflammation and tubular injury, targeting TSP-1
could be a new treatment against the development of CKDs.
RESULTS
Development of renal profibrotic lesions
UUO for 10 days induced tubular dilatation, extracellular
matrix accumulation, interstitial infiltration, and cortical
atrophy (Figure 1a and b, Supplementary Figure S1a and b
online). In most dilated tubules, the epithelium was flattened
or tubular membrane was denuded. Proximal epithelial cell
brush border easily visible by Masson and periodic acid–Schiff
staining in SHAM rats significantly decreased after UUO
(Figure 1a and b, Supplementary Figure S1 online). Cellular
interstitial infiltration increased after UUO (Po0.05, Figure 2a
and b). The number of peritubular capillaries was reduced in
the UUO group compared with the control group (Po0.001,
Figure 3a and b).
Reversal of UUO
UUO relief was followed by progressive renal repair with
epithelial cell replacement and extracellular matrix accumula-
tion remodeling. As early as 7 days after reversible unilateral
ureteral obstruction (RUUO), epithelial replacement of some
tubular segments in the outer medulla was evident, as well as
reappearance of brush border in the proximal tubules (Figures
1aC, D and 2c, d). This regeneration process continued with
time and became evident at 15 days. In the RUUO 15 group,
tubular dilatation and interstitial extracellular matrix accu-
mulation disappeared (Figures 1aC, D and 2c, d). Tubules
were next to each other, tightened as normal renal tissue.
In the RUUO 15 group, morphology of the kidney appeared
normal with very rare scattered area of scarred tissue.
Ten days after UUO, cortical height was significantly lower
compared with SHAM rats (2061±79mm and 3292±255mm,
Po0.005). Fifteen days after UUO release, cortical thickness
significantly improved compared with UUO (2427±48mm
Po0.01), but was still lower than that in the SHAM group,
Po0.05. Glomeruli displayed normal architecture in all
groups. Peritubular capillary regeneration was delayed and
was visible only in the RUUO 15 group (Figure 3c–e).
Functional improvement after UUO relief
To confirm that renal repair and matrix remodeling have
functional consequences, we assessed cell viability in all groups
and renal function in the RUUOþNX subgroup (the group
that underwent right nephrectomy 15 days after reversal).
Tissue viability index significantly decreased after UUO,
Po0.001 (Supplementary Figure S1c online). Release of
ureteral obstruction induced progressive functional improve-
ment. RUUO 7 animals had intermediate level of cell viability,
whereas viability index normalized in RUUO 15 rats. Serum
creatinine was 32±0.9mmol/l in SHAMþNX rats, and
59.3±10.5mmol/l in RUUOþNX right nephrectomized rats,
P¼ 0.076, showing an important recovery of renal function in
the left obstructed kidney, after UUO release. Urine albumin
excretion was not different between these two groups: 222±19
and 260±44mg/mmol creatinine, respectively (P¼ 0.47).
Mechanisms of renal repair and TSP-1 expression
To elucidate cellular mechanisms of renal repair and
remodeling, we assessed cellular proliferation and apoptosis.
Both markers increased markedly after 10 days of UUO,
Po0.001 (Supplementary Figure S1 online). As expected, the
largest part of proliferative cells was observed within the
interstitium in UUO animals (arrow), whereas apoptotic cells
were mostly tubular cells. Interestingly, cellular proliferation
increased further in RUUO 7 rats (Po0.05 vs. UUO group).
At this time, proliferative cells were epithelial tubular cells
(Supplementary Figure S1a online, box). Both apoptosis and
proliferation decreased in the late phase of renal repair, but
were maintained at a higher level than in the SHAM group.
To investigate the mechanisms involved in renal repair, we
tested whether vascular endothelial growth factor (VEGF)
could contribute to peritubular capillary regeneration after
UUO release. Renal VEGF content strongly decreased after 10
days of UUO compared with the SHAM group (Po0.001)
and remained low in the RUUO 7 group (Figure 3c). Renal
VEGF content normalized in the RUUO 15 group.
As TGF-b1 is a major growth factor involved in renal
fibrosis and repair, we assessed TGF-b1 renal content and
type III collagen mRNA expression as a TGF-b-regulated
gene (Figure 2c and d). Total renal TGF-b1 content increased
after UUO (26.7±2.3 pg/mg vs. 1.9±0.3 pg/mg, for UUO
and SHAM groups, respectively (Po0.001)). After 7 days of
release, TGF-b1 content decreased and equaled the SHAM
group levels (5.3±1.8 pg/mg); it was maintained in these
normal levels up to 15 days after release (3.4±1.1 pg/mg).
The elevation of TGF-b1 renal content was associated with
six-fold increase of collagen type III mRNA expression in the
UUO group compared with the SHAM group (Po0.001;
Figure 2c and d). Collagen expression significantly decreased
15 days after release, Po0.01.
Among endogenous TGF-b activators, we assessed TSP-1
expression during renal fibrosis and repair. TSP-1 expression
was faint and was limited to Bowman’s capsule in SHAM rats
(Figure 4a and c). In the UUO group, TSP-1 mRNA and
protein expression increased, and protein was localized in
dilated tubules on tubular membranes (Figure 4a–e). After
ureteral obstruction release, mRNA and protein expression of
TSP-1 were reduced. A faint expression persisted in the most
dilated tubules. Importantly, the protein expression of TSP-1
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was closely related to TGF-b1 content (r¼ 0.749, Po0.0001)
and to collagen III expression (r¼ 0.634, Po0.001) during
fibrosis development and repair.
Genetic deficiency of TSP-1 preserves renal parenchyma
from UUO-induced injury
To confirm the angiogenic effect of TSP-1 inhibition, we
submitted TSP-1 KO and their control wild-type (WT) mice
to UUO for 10 days. UUO induced cortical atrophy, capillary
loss, and tubular lesions in both genotypes. However, these
lesions were less severe in TSP-1 KO mice. UUO induced a
reduction of peritubular capillaries in both groups, but to a
lesser extent in TSP-1 KO mice (Figure 5). VEGF-A and
VEGF-R2 mRNA expressions were similar in the two groups
in normal kidneys and significantly decreased after UUO in
both genotypes, Po0.001. However, TSP-1 KO animals
exhibited a significantly higher expression of VEGF-A and
VEGF-R2 mRNA expression after UUO than WT mice,
Po0.05 (Figure 5). In the same way, renal VEGF content was
similar in normal kidneys in both genotypes and decreased
after UUO in WT mice (Po0.001), but not in TSP-1 KO
mice (P¼ 0.18), and thus it was significantly higher in TSP-1
KO UUO than in WT UUO mice (Po0.05, Figure 5e). To
further assess renal tissue preservation, we measured cortex
thickness and megalin expression as a marker of normal
tubular phenotype. At baseline, cortical thickness was equal
in the two genotypes (1059±31 vs. 1058±30 mm). After
UUO, cortical thickness was significantly reduced by 37.5%
in WT mice (Po0.005), whereas the reduction observed in
KO animals (14%) was not significant. Moreover, cortical
thickness after UUO was significantly higher in TSP-1 KO
mice than in WT mice, i.e., 935±96 mm and 661±64 mm,
respectively, Po0.05 (Figure 6a). Megalin is normally
expressed by proximal tubular epithelial cells and is lost
after tubular injury. Megalin expression was equivalent in the
two genotypes of mice at baseline, i.e., 41.13±2.51% and
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Figure 1 |Representative example of periodic acid–Schiff staining of SHAM, unilateral ureteral obstruction (UUO), and reversible
UUO7, 15 (RUUO 7, 15). (aA) Normal renal architecture seen in the SHAM group. (B) After 10 days of UUO, tubular dilatation, flattening
of the epithelium, loss of proximal epithelial cell brush border, and interstitial infiltration were observed. (C) Seven days after RUUO,
partial epithelial replacement of tubular segments was evident. (D) Complete renal regeneration was observed 15 days after RUUO.
(b) Fifteen days after relief of UUO, cortical height had increased, but cortical atrophy persisted compared with SHAM. Values are
mean±s.e.m., *Po0.05, **Po0.01, ***Po0.005. N, normal.
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43.76±1.31% of cortical area for WT and TSP-1 KO
mice, respectively (Figure 6b). UUO decreased megalin
expression in both groups, Po0.001. Interestingly, megalin
expression was better preserved in TSP-1 KO mice compared
with WT mice, i.e., 17.23±1.67 vs. 12.82±0.67% of
cortical area in WT, Po0.05 (Figure 6b). Altogether, these
results show that TSP-1 KO mice are protected against tubular
injury with a better-preserved renal tissue and capillary
network.
Genetic deficiency of TSP-1 reduces inflammation
from UUO-induced injury
At baseline, interstitial inflammatory cells were rare and
mainly set around arteries. After UUO, important cortical
interstitial cellular infiltration was observed in both geno-
types. Semiquantitative analysis revealed that mean cellular
infiltration score was significantly lower in TSP-1 KO mice,
i.e., 1.9±0.9 compared with 2.8±0.2 in WT mice, Po0.05
(Figure 7a and b). Moreover, tubular cellular casts were only
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Figure 2 | Fibrosis and inflammation assessment after UUO and RUUO 7, 15. (a) Representative example of Masson’s trichrome staining
with cellular interstitial infiltration score. (b) Very rare interstitial cells were observed in the SHAM group. Ten days after unilateral ureteral
obstruction (UUO), cellular interstitial infiltration was markedly increased. Seven days after reversible UUO (RUUO), cellular infiltration
was still important. Fifteen days after RUUO, cellular infiltration significantly decreased compared with UUO rats. Quantitative real-time
PCR of type III collagen. (c) UUO increased type III mRNA expression, which decreased at RUUO 15. (d) Total transforming growth factor-b
(TGF-b) content in the renal cortex in the SHAM group, UUO, RUUO 7, and RUUO 15. Note the significant increase of TGF-b content in UUO.
In RUUO 15, TGF-b level decreased to a level similar to that of SHAM. Values are mean±s.e.m., *Po0.05, **Po0.01, ***Po0.005.
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observed in WT mice. In the non-obstructed kidney, MCP-1
mRNA expression was similar between the two genotypes.
After UUO, MCP-1 mRNA expression increased in both
groups. However, this increase was blunted in KO mice,
Po0.01 (Figure 7c).
Previous studies have demonstrated that TGF-b1 is
necessary for the differentiation of Th17 and T regulatory
cells. These two pathways have opposite effects: Th17 has a pro-
inflammatory role, whereas T regulatory pathway rather limits
inflammation. As renal TGF-b1 level, inflammation, and, in
particular, T lymphocyte (CD3 lymphocytes) infiltration were
lower in UUO TSP-1 KO mice than in UUO WT mice
(Figures 7d and 8a, b), we compared the activation of these
two pathways. Therefore, we studied FOXP3, RORgT, and
IL-17 mRNA expression. FOXP3 and RORgT are transcrip-
tion factors, respectively, expressed by T regulatory and
Th17 cells. IL-17 is a pro-inflammatory cytokine produced
by Th17 cells.
In the normal kidney, IL-17 and RORgT were undetect-
able. FOXP3 was detectable in 6 out of 10 WT animals and
7 out of 11 TSP-1 KO mice, and its level was similar in the
two genotypes. Although the expression of these markers was
several-fold increased following UUO, overexpression of
FOXP3 mRNA was similar between WT and TSP-1 KO
UUO mice (Figure 8f). In contrast, overexpression of RORgT
and IL-17 mRNA was blunted in TSP-1 KO compared with
WT mice after UUO (Figure 8d–f). The ratio of RORgT to
FOXP3 mRNA, used as a marker of the inflammation
balance, was significantly lower in TSP-1 KO compared with
WT mice (Po0.05; Figure 8g). These results suggest that
TSP-1 invalidation reduces UUO-induced inflammation
through inhibition of the Th17 pathway.
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Figure 3 | Evaluation of microvascular network after UUO and RUUO 7, 15. (a) Representative example of peritubular capillary network
revealed by anti-RECA antibody. RECA-positive cells highlight peritubular capillaries (PTC) in SHAM control. The surface area of RECA-
positive cell significantly decreased in unilateral ureteral obstruction (UUO), indicating considerable areas of renal tissue devoid of PTC.
Seven days after reversible UUO (RUUO), the rarefaction of PTC was sustained. After 15 days of RUUO, we observed a significant
regeneration of PTC compared with UUO, but the value was still lower than that in the SHAM control group. (b) Quantification of RECA-
positive cells by morphometric analysis. (c) Vascular endothelial growth factor (VEGF) content in renal cortex of SHAM, UUO, RUUO 7, and
RUUO 15. Renal VEGF content significantly decreased after 10 days of UUO. This decrease was sustained in RUUO 7, but after 15 days of
RUUO renal VEGF content returned to SHAM level. Values are mean±s.e.m., *Po0.05, ***Po0.001, ****Po0.001.
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Figure 4 |Protein and mRNA expression of thrombospondin-1 (TSP-1). (a–c) Unilateral ureteral obstruction (UUO) induced an increased
expression of TSP-1 confirmed by immunofluorescence, (d) real-time PCR, and (e) western blot analysis. (b) In the UUO group, TSP-1
was localized around the most dilated tubules and in dedifferentiated tubular epithelial cells that coexpressed vimentin filament.
(c–e) TSP-1 expression decreased after relief of UUO compared with the UUO group. Values are mean±s.e.m., *Po0.05, **Po0.01,
***Po0.005.
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DISCUSSION
In the present study, we investigated cellular and molecular
mechanisms of renal repair in rats with profibrotic,
inflammatory lesions using the model of ligature relief after
UUO. The kidneys of these animals showed tubular epithelium
replacement, regeneration of peritubular capillaries, remodel-
ing of extracellular matrix accumulation matrix, increased cell
viability, and functional recovery. Repair was progressive, and
renal parenchyma appeared almost normal 15 days after UUO
release. Structural improvement was preceded by cellular
proliferation and the reduction of TSP-1 and TGF-b1
expression. The involvement of TSP-1 in renal profibrotic,
inflammatory lesions was demonstrated using TSP-1 KO mice.
In these mice, the development of UUO lesions was blunted as
evidenced by a lower renal interstitial inflammation and a
better-preserved renal cortex. In addition, we showed that
inflammation was mediated at least in part by MCP-1 and the
activation of Th17 cell pathway.
UUO is widely utilized as a model of tubulointerstitial
fibrosis.14 This model has provided important insights into
the molecular and cellular mechanisms of interstitial fibrosis
and CKD progression.22 Less is known about the mechanisms
that promote tissue remodeling and regeneration. RUUO
offers the advantages for studying mechanisms of renal
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Figure 5 | Evaluation of microvascular network in WT and KO animals at baseline and after UUO. (a) Peritubular capillary network
revealed by anti-MECA antibody in normal (N) and obstructed (unilateral ureteral obstruction, UUO) kidneys of wild-type (WT) and
thrombospondin-1 (TSP-1) knockout (KO) mice. mRNA expression of (c) vascular endothelial growth factor (VEGF)-R2 and (d) VEGF-A by real-
time quantitative PCR. (e) Renal VEGF-A content was assessed by enzyme-linked immunosorbent assay (ELISA). (b) Capillary rarefaction was
alleviated in TSP-1 KO mice as the reduction of expression of (d, e) VEGF-A and (c) its receptor VEGF-R2. Values are mean±s.e.m., *Po0.05,
****Po0.001.
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repair. Different approaches have been used to allow reversal
of obstruction. In rats, surgical procedures included
reimplantation of the ureter into the bladder or removal of
the ureter previously placed between two silicone tubes with
different diameters and ligated.16,17,23 Post-obstructed kidney
function was assessed after contralateral nephrectomy. More
recently, in mice, Cochrane et al.18 used microvascular clips
to facilitate reversal of obstruction followed by bilateral
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Figure 6 |Preservation of renal cortex in WT and KO animals at baseline and after UUO. (a) Representative example of Masson’s
trichrome staining of unilateral ureteral obstruction (UUO) kidneys of wild-type (WT) and thrombospondin-1 (TSP-1) knockout (KO) mice.
(b) Renal megalin expression revealed by anti-megalin antibody in normal (N) and obstructed (UUO) kidneys of WT and TSP-1 KO (KO) mice.
(a) TSP-1 KO mice displayed a better-preserved renal cortex and (b) megalin expression than WT mice after UUO. Values are mean±s.e.m.,
*Po0.05, ***Po0.001, ****Po0.001.
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cannulation of the ureters for functional assessment. To
simplify the microsurgical procedure, we used the vascular
clip and performed a contralateral nephrectomy, which
allowed to measure the renal function of the left kidney
and its recovery.
RUUO resulted in a remarkable restoration of kidney
parenchyma as previously reported.18 Our study brings new
insights into cellular and molecular mechanisms involved in
renal repair. This restoration was characterized by progressive
disappearance of dilated tubules, regeneration of cortical
thickness, and proximal tubular epithelium with reappear-
ance of brush borders, improvement of peritubular capillary
network, and removal of interstitial cell infiltration. Inter-
estingly, the early phase of renal repair (7th day post removal)
was characterized by increased cell proliferation. In a similar
experiment in C57BL/6 strain mice, other investigators found
a higher inflammation score and macrophage infiltration
7 days after release of obstruction than in UUO mice after
6 days of obstruction. In BALB/c mice, only a modest
inflammation was observed, which resolved and normalized
rapidly.24 Interestingly, these results indicate that renal repair
is preceded by cell proliferation and a possible cross talk
between tubular epithelial and macrophage cells. Consistent
with this hypothesis, it has been recently observed that CSF-1,
a hematopoietic growth factor predominantly generated by
tubular epithelial cells, promotes proliferation and activation
of macrophages, and mediates renal repair after ischemia/
reperfusion and UUO.13 Although macrophages have classi-
cally been recognized as active players in progression of
interstitial fibrosis,25 several studies have suggested a
beneficial antifibrotic role of infiltrating macrophages.26 This
apparent opposite role could depend on functional hetero-
geneity and different phenotypes of macrophages.27,28
To determine whether structural improvement has func-
tional consequence, we assessed cell viability and renal func-
tion by measuring plasma creatinine and urinary albumin
excretion. We showed an improvement of cell viability
with important renal function recovery of the previously
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Figure 7 | Evaluation of fibrosis and inflammation in WT and KO animals after UUO. (a) Representative example of Masson’s trichrome
staining of unilateral ureteral obstruction (UUO) kidneys of wild-type (WT) and thrombospondin-1 (TSP-1) knockout (KO) mice and
(b) inflammation score. (c) mRNA expression of MCP-1 by real-time PCR and (d) total transforming growth factor-b (TGF-b) content in the
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obstructed, severely injured kidney. In mice, glomerular
filtration rate of RUUO kidneys was restored from 43 to 88%
after 10 days of UUO.18 Other authors have reported renal
function recovery, but after a shorter time of obstruction.
Glomerular filtration rate and renal blood flow returned to
baseline 14 days after relief of 3 days of UUO.15 These data
clearly show that the restoration of renal structure is
accompanied by functional recovery.
To date, the role of TGF-b1 during the repair process is
unclear. TGF-b1 is a major factor involved in the progression
of renal fibrosis.29 On the other hand, TGF-b1, similar to
FGF2 and VEGF, contributes to vasculogenesis and angio-
genesis, which are required for repair.30 We assessed the active
form of TGF-b1 and the expression of its endogenous
activator TSP-1.19,31 We have previously demonstrated the
involvement of TG2, another endogenous activator of TGF-
b1 during UUO, and showed that mice with genetic
deficiency of TG2 were partly protected from renal fibrosis
because of reduced activation of TGF-b1.3 The increased
expression of TSP-1 has been observed during experimental
and clinical nephropathies.32–35 Besides the activation of
TGF-b1, TSP-1 could contribute to renal fibrosis through its
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Figure 8 |Analysis of lymphocyte infiltration in WT and KO animals after UUO. (a, b) Interstitial infiltration by T lymphocytes revealed by
anti-CD3 antibody and (c–g) mRNA expression of CD3, FOXP3, RORgT, IL-17, and the ratio of RORgT to FOXP3 in the renal cortex in normal
(N) and obstructed (unilateral ureteral obstruction, UUO) kidneys of wild-type (WT) and thrombospondin-1 (TSP-1) knockout (KO) mice.
(a, b) After UUO, interstitial CD3 lymphocyte infiltration was alleviated in TSP-1 KO (KO) mice compared with WT. (c) This was corroborated
with a reduction of CD3 mRNA. The pro-inflammatory Th17 pathway was reduced in TSP-1 KO mice compared with WT after UUO. Values are
mean±s.e.m., *Po0.05, ****Po0.001.
Kidney International (2012) 81, 1226–1238 1235
N Bige et al.: Thrombospondin-1 controls inflammation and renal repair o r ig ina l a r t i c l e
anti-angiogenic effects.36 We found that RUUO was followed
by an early decrease in active TGF-b1 and TSP-1 at day 7,
followed by a reduction in collagen III at day 15. In addition,
the rise in renal VEGF content and peritubular capillaries was
delayed, reaching the highest level at day 15. Different results
of TGF-b during renal repair have been reported by other
groups. In adult rats, after 3-day UUO followed by relief,
total TGF-b1 renal content increased progressively with
time.15 Similarly, the release of UUO did not blunt the
increased mRNA level of TGF-b1 in the post-obstructed
kidney up to 14 days, but it significantly decreased 28 days
after the release of obstruction.37 The reasons for the
discrepancies are unclear. It is possible that the duration of
UUO (3 vs. 10 days) could be a determining factor in the
activation of TGF-b1. In agreement to the hypothesis that
TSP-1 is involved in TGF-b1 activation,34 we found a close
correlation not only between TSP-1 expression and TGF-b1
content, but also with mRNA collagen III expression and
myofibroblasts. These observations further support a leading
role of TSP-1 in the progression of renal fibrosis.
We further investigated the role of TSP-1 using TSP-1 KO
mice38 and showed an angiogenic effect when TSP-1 was
genetically deleted. Although the increase in TSP-1 expres-
sion and the loss of VEGF expression were correlated with
capillary loss and the development of fibrosis in aging rats
and in the remnant kidney model,33,39 the pro-angiogenic
effect of TSP-1 inhibition had never been reported in CKDs
before.40–42 In addition to a better capillary network, TSP-1
KO mice displayed a better-preserved renal cortex and
megalin expression than WT mice after UUO, suggesting a
deleterious effect of TSP-1 in tubular epithelial cells.
Accordingly, it has been shown that addition of TSP-1
peptide in rat proximal tubular cell culture favored cell
apoptosis through caspace-3 activation.43 Moreover, TSP-1-
null mice exposed to renal ischemia/reperfusion injury
demonstrated significant preservation of tubular structures.43
We investigated the mechanisms of TSP-1-induced renal
inflammation because we observed less renal interstitial
inflammation in TSP-1 KO mice compared with WT mice.
We found that at least two mechanisms might contribute to
decreased inflammation in TSP-1 KO mice: reduced activa-
tion of MCP-1 and decreased rates of CD3 T-cell infiltration
through inhibition of the TGF-b1-induced Th17 path-
way.44,45 In support to our hypothesis, TSP-1 KO mice also
exhibited lower levels of MCP-1 than WTanimals in a wound
healing model.46 Other authors have shown that, in vitro,
TSP-1 induced MCP-1 release by mononuclear cells in a
dose-dependent manner.47 Th17-associated transcription
factors RORgT and interleukin 17 mRNA were not detectable
in unobstructed kidneys, but were significantly increased
after UUO. However, this increase was blunted in TSP-1 KO
mice. This result could be explained by the blunted levels of
TGF-b1 in KO animals. Indeed, two recent studies revealed
that TSP-1 participates in the development of experimental
autoimmune encephalomyelitis by enhancing T-cell infiltra-
tion and the differentiation of Th17 cells in a TGF-b1-
dependent manner.48,49 The role of Th17 cells in renal injury
was previously studied in experimental glomerulonephritis in
which IL-23- and IL-17-deficient mice developed less severe
nephritis compared with WT animals.47 In our model, TSP-1
KO mice showed reduced expression of IL-17 and RORgT
associated with less severe tubular lesions. Altogether, these
results suggest that Th17 cells might participate in tubular
and glomerular injury.
In conclusion, our data provide new clues to the under-
standing of the mechanisms of renal repair after UUO relief.
Structural regeneration was associated with functional
recovery. Among the early and driving events of renal repair
in RUUO are cell proliferation and decrease in TSP-1 and
TGF-b1 levels. TSP-1 appears to be an important mediator,
because its deletion is associated with protection against
UUO induced renal inflammation and fibrosis. Thus,
targeting TSP-1 could limit fibrosis development and favor
renal repair in CKD patients.
MATERIALS AND METHODS
Animals and experimental design
UUO surgery was performed on male Sprague-Dawley rats (Charles
River Laboratories, Arbresle, France) weighing 150–200 g. Surgery
was performed under general anesthesia after intraperitoneal
injection of pentobarbital sodium 65mg/kg. After laparotomy, the
left ureter was clamped with a non-traumatic microvascular clip
(S&T Fine Science Tools, North Vancouver, CA). In control rats
(SHAM), the ureter was manipulated but not ligated.
A first protocol was performed to study the mechanisms of
renal repair after UUO release (RUUO). Ten days after UUO, the
vascular clip was removed and rats were killed 7 or 15 days after
UUO release (RUUO 7 and 15, respectively). They were compared
with SHAM control, and rats were killed after 10 days of UUO
(n¼ 6 per group). Reversal of obstruction was confirmed by
resolution of hydronephrosis. The RUUO surgery was successful
in more than 75% of the animals. Failure was due to excessive
adhesions around the ligation, and those animals were excluded on
gross examination.
To assess the renal function of the previously obstructed kidney
at RUUO 15, a second protocol was performed. Two weeks after
RUUO, the contralateral kidney was removed, leaving the previously
obstructed kidney as a life-sustaining organ (RUUOþNX). Plasma
creatinine and urinary protein excretion were measured 15 days
later, to allow hemodynamic and renal function recovery after
surgery. Values were compared with the values of SHAM group of
rats that were killed 15 days after uninephrectomy (SHAMþNX)
without UUO (n¼ 5 per group).
To determine the role of TSP-1, TSP-1 knockout (TSP-1 KO)
mice generated on a C57/Bl6J background38 and age-matched WT
mice underwent UUO (8- to 10-week-old, n¼ 13 and 12, respectively)
by double ligation of the left ureter under general anesthesia after
intraperitoneal injection of xylazin and ketamin. Animals were killed
10 days after UUO. The right unobstructed kidney was used as
normal control for each mouse.
Detailed methodology is described in the Supplementary Methods
online.
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